Antiretroviral therapy
Author(s)
Bibliographic Information
Antiretroviral therapy
ASM Press, c2001
Available at 1 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographies and index
Description and Table of Contents
Description
Authoritative chapters by American and European investigators review new approaches to therapy based on fundamental discoveries on retrovirus infection and reproduction cycle. The volume also covers new approaches to therapy such as the determination of viral load, resistance problems, and the outlook for future advances in antiretroviral therapy.
Table of Contents
1. Kinetics of Human Immunodeficiency Virus Type 1 Replication and Therapy (Bharat Ramratnam and Martin H. Markowitz) 2. Cellular Receptors as Targets for Anti-Human Immunodeficiency Virus Agents (Dominique Schols and Erik De Clercq) 3. Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (J. Balzarini and Erik De Clercq) 4. Nonnucleoside Reverse Transcriptase Inhibitors (J. Balzarini, R. Esnouf, and Erik De Clercq) 5. Human Immunodeficiency Virus Type 1 Integrase-Targeted Inhibitor Design (Nouri Neamate, Christophe Marchand, Heather E. Winslow, and Yves Pommier) 6. Inhibitors of Transcription and Transactivation and Anti-Human Immunodeficiency Virus Agents (Jonathan Karn) 7. Oligonucleotides as Antiretroviral Agents (A. Kirk Field) 8. Protease Inhibitors as Anti-Human Immunodeficiency Virus Agents (Dale J. Kempf, Akhteruzzaman Molla, and Ann Hsu) 9. Glycoprotein Processing Enzymes as a Target for Human Immunodeficiency Virus Chemotherapy (A. Stanley Tyms) 10. Cellular Factors as Targets for Anti-Human Immunodeficiency Virus Therapy (Masanori Baba) 11. Therapeutic Human Immunodeficiency Virus Vaccines: Concept (Current Status, and Future Directions, John S. Lambert, Robert R. Redfield, and Edmund C. Tramont) 12. Clinical Usefulness of Human Immunodeficiency Virus Drug Resistance Monitoring (Anne-Mieke Vandamme and Erik De Clercq) 13. Emergence of Drug-Resistant Human Immunodeficiency Virus Type 1 (HIV-1) Variants and their Impact on Antiretroviral Therapy of HIV-1 Infection (Mark F. Kavlick and Hiroaki Mitsuya) 14. Combination Antiretroviral Therapy (Cecile Tremblay, Joan C. Kaplan, and Martin S. Hirsch) 15. Drug-Drug Interactions in Human Immunodeficiency Virus Infections (Charles W. Flexner and Stephen C. Piscitelli)
by "Nielsen BookData"